Trials / Active Not Recruiting
Active Not RecruitingNCT07105384
Quantification Tools for a Novel Tau PET Marker in a Rare Neurological Disease: 18F-PI-2620 in Progressive Supranuclear Palsy
- Status
- Active Not Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 66 (estimated)
- Sponsor
- Fundacion Clinic per a la Recerca Biomédica · Academic / Other
- Sex
- All
- Age
- 40 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
The aim of this clinical trial is to explore the potential of novel 2nd generation tau PET radiotracers as biomarkers in cases suggestive of progressive supranuclear palsy (PSP), an atypical form of parkinsonism.
Detailed description
Phase II, uncontrolled, single-center, uncontrolled, drug-controlled clinical trial for the evaluation of a diagnostic test (PI-2620).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| COMBINATION_PRODUCT | Radiotracer | Patients will receive a brain tau radiotracer |
Timeline
- Start date
- 2025-02-04
- Primary completion
- 2028-06-20
- Completion
- 2028-12-20
- First posted
- 2025-08-05
- Last updated
- 2025-08-05
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT07105384. Inclusion in this directory is not an endorsement.